CSIRO Adopts Pairwise’s CRISPR Platform to Boost Agricultural Innovation

Pairwise, a global leader in precision breeding, has announced a major commercial licensing agreement with CSIRO, Australia's national science agency. This partnership grants CSIRO access to the Fulcrum® platform, a sophisticated suite of CRISPR-based gene editing tools, including the proprietary SHARC™ enzyme. The agreement marks one of the most comprehensive licenses issued by Pairwise to date, spanning applications across plants, livestock, aquaculture, and microbes.

The integration of the Fulcrum® platform into CSIRO's research initiatives is expected to accelerate the development of new traits in Australian agriculture significantly. Dr. Jason Geijskes, Trait Innovation Group Leader at CSIRO, emphasized that these precision breeding technologies will support farm productivity and sustainability. By streamlining the discovery process, the agency aims to deliver impactful solutions that benefit both farmers and consumers on a global scale.

This collaboration underscores the growing versatility of gene editing in addressing complex environmental and food security challenges. Tom Adams, CEO of Pairwise, noted that the broad scope of the license reflects the power of CRISPR technology to transform diverse biological sectors. As CSIRO harnesses these advanced tools, the partnership is poised to drive a new era of scientific innovation, creating climate-resilient and more nutritious food sources for the future.

For more details, read the news article on the Pairwise website.